Xenon Pharmaceuticals Inc (XENE)
Cost of Revenue
$77.67M
TTM · Period ending: · USD
XENE Cost of Revenue
Latest reported$77.67Mperiod ending
Latest reported$77.67Mperiod ending
XENE TTM Cost of Revenue ($6.21M → $77.67M)
TTM cost of revenue
High-resolution chart · PNG
XENE cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 77,665,000 | |
| 78,297,000 | |
| 78,297,000 | |
| 77,686,000 | |
| 632,000 | |
| 0 | |
| 599,000 | |
| 599,000 | |
| 599,000 | |
| 599,000 | |
| 0 | |
| 0 | |
| 29,431,000 | |
| 51,577,000 | |
| 70,937,000 | |
| 92,824,000 | |
| 82,284,000 | |
| 78,515,000 | |
| 75,463,000 | |
| 68,543,000 | |
| 49,652,000 | |
| 31,275,000 | |
| 14,967,000 | |
| 0 | |
| 9,751,000 | |
| 17,956,000 | |
| 27,093,000 | |
| 33,495,000 | |
| 29,744,000 | |
| 26,955,000 | |
| 23,386,000 | |
| 23,381,000 | |
| 24,545,000 | |
| 25,238,000 | |
| 25,573,000 | |
| 19,184,000 | |
| 12,511,000 | |
| 6,744,000 | |
| 1,130,000 | |
| 1,690,000 | |
| 1,821,000 | |
| 2,188,000 | |
| 2,762,000 | |
| 3,232,000 | |
| 4,370,000 | |
| 5,290,000 | |
| 5,903,000 | |
| 6,671,000 | |
| 6,386,000 | |
| 6,221,500 | |
| 6,210,000 | |
| 6,476,000 | |
| 7,073,000 |